Healthcare provider profile · identity verified

Joseph Patrick Molnar, D.O.

Family Practice · CHESTER, IL · NPI 1306881412

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	398	104
Levothyroxine Sodium	Levothyroxine Sodium	391	98
Atorvastatin Calcium	Atorvastatin Calcium	386	110
Lisinopril	Lisinopril	378	103
Amlodipine Besylate	Amlodipine Besylate	362	83
Metoprolol Succinate	Metoprolol Succinate	353	88
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	327	68
Hydrochlorothiazide	Hydrochlorothiazide	312	87
Gabapentin	Gabapentin	308	60
Alprazolam	Alprazolam	227	37
Furosemide	Furosemide	208	58
Potassium Chloride	Potassium Chloride	204	49
Metformin Hcl	Metformin Hcl	201	54
Metoprolol Tartrate	Metoprolol Tartrate	190	41
Tamsulosin Hcl	Tamsulosin Hcl	184	45
Simvastatin	Simvastatin	178	46
Losartan Potassium	Losartan Potassium	176	47
Montelukast Sodium	Montelukast Sodium	169	37
Pantoprazole Sodium	Pantoprazole Sodium	167	46
Eliquis	Apixaban	156	29
Tramadol Hcl	Tramadol Hcl	151	34
Rosuvastatin Calcium	Rosuvastatin Calcium	142	38
Clopidogrel	Clopidogrel Bisulfate	132	36
Albuterol Sulfate Hfa	Albuterol Sulfate	130	35
Lorazepam	Lorazepam	125	30
Azithromycin	Azithromycin	116	77
Prednisone	Prednisone	116	74
Trazodone Hcl	Trazodone Hcl	116	30
Famotidine	Famotidine	115	29
Carvedilol	Carvedilol	113	25
Diclofenac Sodium	Diclofenac Sodium	113	28
Allopurinol	Allopurinol	106	31
Venlafaxine Hcl Er	Venlafaxine Hcl	106	14
Tizanidine Hcl	Tizanidine Hcl	101	24
Pregabalin	Pregabalin	100	20
Duloxetine Hcl	Duloxetine Hcl	98	23
Clonazepam	Clonazepam	90	15
Ozempic	Semaglutide	84	16
Fluoxetine Hcl	Fluoxetine Hcl	83	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	21
Buspirone Hcl	Buspirone Hcl	79	12
Meloxicam	Meloxicam	76	23
Atenolol	Atenolol	74	14
Sertraline Hcl	Sertraline Hcl	73	20
Citalopram Hbr	Citalopram Hydrobromide	72	23
Celecoxib	Celecoxib	68	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	68	13
Metformin Hcl Er	Metformin Hcl	67	15
Mounjaro	Tirzepatide	67	suppressed
Sucralfate	Sucralfate	65	20
Glipizide	Glipizide	64	18
Hydralazine Hcl	Hydralazine Hcl	64	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	16
Temazepam	Temazepam	61	14
Mirtazapine	Mirtazapine	57	13
Cefdinir	Cefdinir	56	44
Amitriptyline Hcl	Amitriptyline Hcl	55	13
Finasteride	Finasteride	54	17
Xarelto	Rivaroxaban	54	13
Spironolactone	Spironolactone	51	18
Quetiapine Fumarate	Quetiapine Fumarate	50	12
Bupropion Xl	Bupropion Hcl	48	13
Alendronate Sodium	Alendronate Sodium	47	suppressed
Jardiance	Empagliflozin	46	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	12
Fluticasone Propionate	Fluticasone Propionate	44	22
Diazepam	Diazepam	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Glipizide Er	Glipizide	43	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	26
Esomeprazole Magnesium	Esomeprazole Magnesium	40	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	12
Lovastatin	Lovastatin	37	11
Cephalexin	Cephalexin	35	25
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	15
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	23
Fluconazole	Fluconazole	28	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Methylprednisolone	Methylprednisolone	27	21
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	25	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	15
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Torsemide	Torsemide	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Dutasteride	Dutasteride	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Metolazone	Metolazone	21	suppressed
Topiramate	Topiramate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Levofloxacin	Levofloxacin	20	11
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Amoxicillin	Amoxicillin	16	13
Cilostazol	Cilostazol	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Estradiol	Estradiol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Nystatin	Nystatin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Baclofen	Baclofen	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Enalapril Maleate	Enalapril Maleate	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Constulose	Lactulose	13	suppressed
Glucagon Emergency Kit	Glucagon	13	suppressed
Orencia	Abatacept/Maltose	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Colchicine	Colchicine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Methimazole	Methimazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error